High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
about
Regulating the immune system: the induction of regulatory T cells in the peripheryComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisAdvances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ TransplantationRegulatory T cells in autoimmune neuroinflammationT Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-AntitrypsinTolerance induction in experimental autoimmune encephalomyelitis using non-myeloablative hematopoietic gene therapy with autoantigen.Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplantImmunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner.Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.The scope of quantitative polymerase chain reaction assays in clinical molecular pathologyChronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response.Immunobiology of allogeneic peripheral blood mononuclear cells mobilized with granulocyte-colony stimulating factor.In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling.The role of HLA-G in immunity and hematopoiesis.Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patientsMolecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans.Mechanisms of interleukin-10-mediated immune suppression.Molecular identification of porcine interleukin 10: regulation of expression in a kidney allograft model.Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice.Defective regulatory and effector T cell functions in patients with FOXP3 mutations.Natural regulatory T cells in autoimmunity.A higher risk of acute rejection of human kidney allografts can be predicted from the level of CD45RC expressed by the recipients' CD8 T cells.OX40 ligand shuts down IL-10-producing regulatory T cells.Type 1 regulatory T cells (Tr1) in autoimmunityInduction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cellsInterleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo.Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donorHistorical overview of immunological tolerance.Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.Mechanisms of suppression by suppressor T cells.Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.Mechanisms of immunological tolerance in central nervous system inflammatory demyelination.Isolation and characterization of human interleukin-10-secreting T cells from peripheral blood.Peptide-based instruction of suppressor commitment in naïve T cells and dynamics of immunosuppression in vivo.Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells.Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics
P2860
Q24796969-5EDB14E0-8E3F-4ED9-8B07-FB5B8B850045Q26779956-39F545EA-8775-4C11-97FB-95C8E02EE4D8Q26801808-9249A76A-E84F-4D5B-BB27-32C5F73AAAA5Q26825063-70956629-18B6-4013-8647-E6D0D0E537A5Q26829272-07C81677-25F2-4B6F-9870-535B41323EC5Q33416725-A70CDD10-9135-4907-A649-DC5C9F0ABA75Q33604471-44B38D1A-4AA2-4089-B8EB-2883915B9038Q33608752-9152BEE7-2943-4434-8DA8-AD91B69B218CQ33715925-76F41AA8-2141-4A56-BCB6-3628830EF73EQ33837963-11603CF1-0BE8-43A0-A8E6-B0CDA61FB8ECQ33867180-4849B5AA-436C-44D6-BDD8-BA6854434562Q33986118-0AF87AD7-7DEE-4E5A-8605-012A4F46DAE7Q34008864-C44D8FA9-624B-4DA3-BAD1-0407275760A1Q34024865-609B8206-38BC-486D-B8C8-9122BB5FD5A5Q34195964-4DAC80CA-3A34-4211-87DE-2AB07A5288BFQ34242160-5090C834-8CB7-49DC-9F50-6C766537C41FQ34271609-94603B3D-BFC0-4FBE-89E3-2A6DE0DD07FCQ34285968-DA9CCBEC-B922-440D-A6C9-F43CCD3BFE9FQ34504119-CEB93BC2-5A01-4EB7-8659-DD290C5A2AC4Q34565123-42CEA57F-6061-443E-876F-A27E8DDE18F8Q34648860-6D828BD9-0FAA-41C3-BD42-EABACAA5DFDEQ34676250-3650AC6F-E75B-4501-97F3-449860558148Q34874489-74D0451E-CF84-4C41-9AFD-73659950BE90Q35016533-526CD0E3-35D8-4109-A2C6-C10D7B13A0C9Q35226496-6CC2AF08-65FD-4039-A265-DF6B7209A812Q35592657-86E1EE22-AC15-4776-AF15-9B4AAC668F46Q35679596-FD943BC9-AD84-461A-A6F5-035D4A6535D8Q35787936-AC155DB3-DB9B-4873-9CA8-976C8D5083A7Q35846752-BA74A47F-6274-448C-8746-432D3886CE93Q35847781-C08B573D-0E6E-4F75-BB2B-A22E34AEDF9EQ35853778-0780D607-D1BA-49BC-96FA-C30386AA719FQ35902903-3089FA32-168D-4251-AF20-29003EAF03ACQ36078047-2BB4F2C1-27F1-4F3D-971E-F8A3E22A38EFQ36085011-4D36946D-304F-4DEB-A495-87CED8BB9CFEQ36095922-F9A16D32-FA00-4275-B8B3-3B06E104746DQ36103122-4624F55A-B613-4AD9-AAFB-56DD356E47A6Q36161507-8030FB15-0906-43F3-8D5B-A6E534ECD729Q36220670-A6E0A72D-1A65-4AB2-87D4-1BF16967C59FQ36364150-F9426201-7748-4594-89CB-2F957A76A09BQ36364647-EA0309EB-C5F9-487C-B988-EA6CE4C4DC5A
P2860
High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@ast
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@en
type
label
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@ast
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@en
prefLabel
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@ast
High levels of interleukin 10 ...... ched hematopoietic stem cells.
@en
P2093
P2860
P356
P1476
High levels of interleukin 10 ...... tched hematopoietic stem cells
@en
P2093
J E de Vries
J L Touraine
M G Roncarolo
R Bacchetta
P2860
P304
P356
10.1084/JEM.179.2.493
P407
P577
1994-02-01T00:00:00Z